These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1231881)

  • 41. [Behavior of HGH in essential obesity and its changes after a low-calorie diet].
    Ghionni A; Colucci M; Del Giudice N; Palomba D; Jacono G
    Folia Endocrinol; 1971; 24(3):274-80. PubMed ID: 5171728
    [No Abstract]   [Full Text] [Related]  

  • 42. [Growth hormone, insulin, glucemia and plasmatic free fatty acids after arginine administration (author's transl)].
    Portugal-Alvarez J; Enríquez L; Zamarrón A; Vila T; Catalá E; Velasco-Martín A
    Rev Esp Fisiol; 1973 Dec; 29(4):289-91. PubMed ID: 4791170
    [No Abstract]   [Full Text] [Related]  

  • 43. [Effect of a beta-blocking agent on the adipokinetic action of corticotropin in humans].
    Giordano G; Marcenaro A; Pompei A
    Arch Maragliano Patol Clin; 1970; 26(4):239-57. PubMed ID: 4394963
    [No Abstract]   [Full Text] [Related]  

  • 44. Regulation of human lipolysis. In vivo observations on the role of adrenergic receptors.
    Burns TW; Mohs JM; Langley PE; Yawn R; Chase GR
    J Clin Invest; 1974 Jan; 53(1):338-41. PubMed ID: 4808646
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Amantadine potentiation of G.H. relase evoked by L-dopa and its inhibition by nonesterified fatty acids].
    Cabezas-Cerrato J; Casanueva Freijo F; Villanueva Aranguren L; Avila C; Fernández-Cruz A
    Rev Clin Esp; 1977 May; 145(3):165-8. PubMed ID: 866739
    [No Abstract]   [Full Text] [Related]  

  • 46. Diminished growth hormone secretion in blind males after L-dopa stimulation.
    Fatranská M; Jurcovicová J; Németh S; Vigas M
    Endocrinol Exp; 1988 Dec; 22(4):243-8. PubMed ID: 3243205
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Effect of carbidopa and L-dopa combination on the secretion of growth hormone in normal subjects and in patients with Parkinsonism].
    Nurzia A; Vacca U; Pirro R; Cerone G
    Clin Ter; 1975 Aug; 74(3):265-70. PubMed ID: 1227747
    [No Abstract]   [Full Text] [Related]  

  • 48. [Somatotropin secretion stimulation test for diencephalic and pituitary diseases, with special reference to the tests using arginine and insulin].
    Nakagawa K; Okamoto M; Horiuchi Y; Mashimo K
    Saishin Igaku; 1969 Nov; 24(11):2333-9. PubMed ID: 5359819
    [No Abstract]   [Full Text] [Related]  

  • 49. Study on growth hormone and prolactin secretions in myotonic dystrophy.
    Canal N; Smirne S; Comi G; Guidobono F; Pecile A; Caviezel F
    Acta Neurol Belg; 1982; 82(3):178-84. PubMed ID: 7051737
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Under-responsiveness of growth hormone secretion after L-dopa and deep sleep stimulation in obese subjects.
    Laurian L; Oberman Z; Ayalon D; Cordova T; Herzberg M; Horer E; Harell A
    Isr J Med Sci; 1975 May; 11(5):482-7. PubMed ID: 1158662
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Response of hGH to insulin hypoglycemia and to bromocriptine before and after the administration of L-dopa in primary hypothyroidism].
    Campino C; Pumarino H; Michelsen H; Piraino P; Generini G; Bruggendieck B
    Rev Med Chil; 1985 Apr; 113(4):296-300. PubMed ID: 3915142
    [No Abstract]   [Full Text] [Related]  

  • 52. Effects of propranolol on HGH secretion after endovenous tolbutamide load in obese subjects.
    Carducci Artenisio A; Sprovieri M; Albanese MC; Allegra V; Ragonese F; Corsi V
    Horm Metab Res; 1973 Nov; 5(6):473-4. PubMed ID: 4767004
    [No Abstract]   [Full Text] [Related]  

  • 53. [Levodopa and somatotropic hormone in diabetes].
    Carducci Artenisio A; Ragonese F; Martelli G; Forte F; Campisi R; Consolo F
    Boll Soc Ital Biol Sper; 1978 Oct; 54(20):1972-7. PubMed ID: 753286
    [No Abstract]   [Full Text] [Related]  

  • 54. [Somatotropic function of the pituitary in obesity].
    Epshteĭn EV
    Vrach Delo; 1976 Jul; (7):105-8. PubMed ID: 997441
    [No Abstract]   [Full Text] [Related]  

  • 55. Mechanisms involved in the exercise-induced increase in glucagon secretion in rats.
    Luyckx AS; Lefebvre PJ
    Diabetes; 1974 Feb; 23(2):81-93. PubMed ID: 4811512
    [No Abstract]   [Full Text] [Related]  

  • 56. Secretion of growth hormone after L-dopa stimulation in patients with renal failure treated with dialyses.
    Kuska J; Kokot F; Sledziński Z
    Acta Med Pol; 1979; 20(3):217-26. PubMed ID: 517160
    [No Abstract]   [Full Text] [Related]  

  • 57. Evaluation of growth hormone secretion during sleep and after L-dopa.
    Kulesza B; Blaim A; Palińska-Cudnoch M
    Mater Med Pol; 1977; 9(1):34-6. PubMed ID: 875451
    [No Abstract]   [Full Text] [Related]  

  • 58. [A low response of pituitary growth hormone secretion in the patient with diabetes mellitus after intravenous administration of L-dopa (author's transl)].
    Shimoda S; Takemura Y; Ieiri T; Kasai K; Kikuchi T
    Nihon Naibunpi Gakkai Zasshi; 1975 Jan; 51(1):9-17. PubMed ID: 1171032
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of adrenergic receptor blackade on nicotinic acid-induced plasma FFA rebound.
    Blackard WG; Heidingsfelder SA
    Metabolism; 1969 Mar; 18(3):226-33. PubMed ID: 4975789
    [No Abstract]   [Full Text] [Related]  

  • 60. Effect of adrenergic-blocking agents on plasma growth hormone. Response to L-5-hydroxytryptophan (5-HTP) in man.
    Nakai Y; Imura H
    Endocrinol Jpn; 1974 Dec; 21(6):493-7. PubMed ID: 4549429
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.